This content is machine translated Cannabis for schizophrenia CBD pre-treatment could exacerbate side effects A significant proportion of people with schizophrenia use cannabis, with around one in five meeting the criteria for a comorbid cannabis use disorder, for which there are still limited effective...…
View Post 11 min This content is machine translated Type 2 diabetes: cardiovascular risk reduction is realistic Modern active ingredients and lifestyle – every step counts Although diabetics have an increased risk of developing cardiovascular diseases such as myocardial infarction, heart failure or stroke, scientific data suggests that protective effects can be achieved through the best...…
View Post 4 min This content is machine translated Lichen sclerosus Interim analysis of a new register So far, 60 patients1 with lichen sclerosus were included in the registry launched in Germany. The mean age of the included patients is 54 years 2. An interim assessment shows...…
View Post 8 min This content is machine translated Urothelial carcinoma Immune and targeted therapy options: Evidence situation 2025/2026 The treatment of urothelial carcinoma has developed significantly in recent years. Modern immunotherapies, antibody-drug conjugates (ADCs) and targeted substances complement conventional chemotherapies and increasingly enable individualized treatment strategies. New data...…
View Post 5 min This content is machine translated SGLT2 inhibitors for type 2 diabetes and CKD Prediction model beats albuminuria threshold SGLT2 inhibitors also significantly reduce the risk of kidney disease progression in patients with type 2 diabetes and preserved kidney function, whereby the relative benefit is independent of albuminuria status....…
View Post 4 min This content is machine translated Risk of psychosis Modulate cortical excitatory activity with diazepam Individuals at clinical high risk for psych osis (CHRp) have an estimated 27% chance of developing a psychotic disorder within three years, but there are currently no established preventive pharmacological...…
View Post 6 min This content is machine translated MASLD/MASH: lifestyle, pharmacotherapy, bariatric procedures Addressing metabolic drivers and counteracting fibrosis Steatotic liver diseases that are not associated with alcohol consumption are now referred to as metabolic steatotic liver disease (MASLD) or metabolic dysfunction-associated steatohepatitis (MASH). There is now no need...…
View Post 9 min This content is machine translated Experiences from the EFFORT studies Solutions to the malnutrition dilemma The term malnutrition encompasses more than just insufficient food intake; it is an independent clinical picture with clearly defined effects on complication rates, functionality and mortality, which can be influenced...… CME-Test
View Post 6 min This content is machine translated Chronic urticaria: new treatment alternatives in sight If antihistamines are not sufficient and IgE levels are low Chronic urticaria often leads to a high level of suffering, but new treatment options are on the way – a lot has happened since the publication of the current S3...…
View Post 12 min This content is machine translated Treatable risk factor Depression and cardiovascular mortality New meta-analyses, the first ESC consensus document on mental health and heart disease and groundbreaking Lancet dataon antidepressant drugs show: Depression is an independent, quantifiable and treatable risk factor for...…
View Post 6 min This content is machine translated Hypertrophic cardiomyopathies (HCM) How do myosin inhibitors perform in different HCM phenotypes? Cardiac myosin inhibitors have been developed as a targeted therapeutic option for modulating sarcomere function. While in clinical trials in obstructive hypertrophic cardiomyopathy they brought about a greater improvement in...…
